← All organizations
Highest phase reached
Phase 2
First clinical trial
May 14, 2014Last known activity
Feb 6, 2023
Timeline
2000s
- Jun 1, 2008
Invicro— Founded
Drugs by trial phase (14 distinct, 17 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (11 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (26)
- NCT05725005CollaboratorPhase 1Feb 6, 2023
- NCT05274568Lead sponsorPhase 1Jan 31, 2022
- NCT05063357CollaboratorPhase 1Dec 31, 2021
- NCT05164536Lead sponsorPhase 1Aug 27, 2021
- NCT05164536Overall official - principal investigatorPhase 1Aug 27, 2021
- NCT05009199Lead sponsorPhase 1Jun 24, 2021
- NCT05009199Overall official - principal investigatorPhase 1Jun 24, 2021
- NCT05005819Overall official - principal investigatorPhase 1May 25, 2021
- NCT05005819Lead sponsorPhase 1May 25, 2021
- NCT06445465OfficialEarly Phase 1Dec 24, 2020
- NCT06445465Lead sponsorEarly Phase 1Dec 24, 2020
- NCT04116164CollaboratorEarly Phase 1Sep 18, 2019
- NCT04141150Overall official - principal investigatorPhase 2Aug 19, 2019
- NCT04851392CollaboratorN/AMar 11, 2019
- NCT03719482Overall official - principal investigatorPhase 1Oct 5, 2018
Details
- Founded
- Boston, MA, US Jun 1, 2008
- Last known activity
- Feb 6, 2023